Evidence map›Paper›PMID 24439028›Full record

ArticleNeurobiology of aging2014

Search for age-related macular degeneration risk variants in Alzheimer disease genes and pathways.

Mark W Logue, Matthew Schu, Badri N Vardarajan, John Farrell, Kathryn L Lunetta, Gyungah Jun, Clinton T Baldwin, Margaret M Deangelis, Lindsay A Farrer

Abstract read
In one paragraph

Article in Neurobiology of aging, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 1 pooled it
4.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 1 synthesis or guideline pooled it, 61 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Pathogenic Single Nucleotide Polymorphisms on Autophagy-Related Genes.International journal of molecular sciences · 2020
    Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Mark W LogueDepartment of Medicine (Biomedical Genetics), Boston University School of Medicine, Boston, MA, USA; Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA.
Matthew SchuDepartment of Medicine (Biomedical Genetics), Boston University School of Medicine, Boston, MA, USA.
Badri N VardarajanDepartment of Medicine (Biomedical Genetics), Boston University School of Medicine, Boston, MA, USA.
John FarrellDepartment of Medicine (Biomedical Genetics), Boston University School of Medicine, Boston, MA, USA.
Kathryn L LunettaDepartment of Biostatistics, Boston University School of Public Health, Boston, MA, USA.
Gyungah JunDepartment of Medicine (Biomedical Genetics), Boston University School of Medicine, Boston, MA, USA; Department of Ophthalmology, Boston University School of Medicine, Boston, MA, USA; Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA.
Clinton T BaldwinDepartment of Medicine (Biomedical Genetics), Boston University School of Medicine, Boston, MA, USA.
Margaret M DeangelisJohn A. Moran Eye Center, University of Utah, Salt Lake City, UT, USA.
Lindsay A FarrerDepartment of Medicine (Biomedical Genetics), Boston University School of Medicine, Boston, MA, USA; Department of Neurology, Boston University School of Medicine, Boston, MA, USA; Department of Ophthalmology, Boston University School of Medicine, Boston, MA, USA; Department of Epidemiology, Boston University School of Public Health, Boston, MA, USA; Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA. Electronic address: farrer@bu.edu.
Boston University · USUniversity of Utah · US

Funding

National Centralized Repository for Alzheimer's Disease and Related Dementias (NCRAD)U24AG021886 · NIA · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI TATIANA M. FOROUD · 2002 to 2026
$119.8M
Alzheimer's Disease Genetics ConsortiumU01AG032984 · NIA · UNIVERSITY OF PENNSYLVANIA · PI SCHELLENBERG, GERARD DAVID · 2009 to 2024
$60.4M
Neuropathology CoreP30AG013846 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI KOWALL, NEIL W. · 1996 to 2020
$29.1M
Alzheimer Disease Genetic Architecture in African AmericansR01AG048927 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI Lindsay A. Farrer · 2015 to 2026
$8.4M
SIBLING STUDY OF AGE-RELATED MACULAR DEGENERATIONR01EY014458 · NEI · UNIVERSITY OF UTAH · PI DEANGELIS, MARGARET M · 2003 to 2010
$4.2M
Multi-ethnic genome-wide Alzheimer's association studyR01AG025259 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI FARRER, LINDSAY A. · 2006 to 2010
$2.6M
NEI NIH HHS R01 EY014458NEI NIH HHS R01-EY0144581NIA NIH HHS P30 AG013846NIA NIH HHS PG30-AG13846NIA NIH HHS R01 AG025259NIA NIH HHS R01-AG025259NIA NIH HHS R01 AG048927NIA NIH HHS U01 AG032984NIA NIH HHS U01-AG032984NIA NIH HHS U24 AG021886
6 · The paper itself

Abstract

Several lines of inquiry point to overlapping molecular mechanisms between late-onset Alzheimer disease (AD) and age-related macular degeneration (AMD). We evaluated summarized results from large genome-wide association studies for AD and AMD to test the hypothesis that AD susceptibility loci are also associated with AMD. We observed association of both disorders with genes in a region of chromosome 7, including PILRA and ZCWPW1 (peak AMD SNP rs7792525, minor allele frequency [MAF] = 19%, odds ratio [OR] = 1.14, p = 2.34 × 10(-6)), and with ABCA7 (peak AMD SNP rs3752228, MAF = 0.054, OR = 1.22, p = 0.00012). Next, we evaluated association of AMD with genes in AD-related pathways identified by canonical pathway analysis of AD-associated genes. Significant associations were observed with multiple previously identified AMD risk loci and 2 novel genes: HGS (peak SNP rs8070488, MAF = 0.23, OR = 0.91, p = 7.52 × 10(-5)), which plays a role in the clathrin-mediated endocytosis signaling pathway, and TNF (peak SNP rs2071590, MAF = 0.34, OR = 0.89, p = 1.17 × 10(-5)), which is a member of the atherosclerosis signaling and the LXR/RXR activation pathways. Our results suggest that AMD and AD share genetic mechanisms.

Indexed as

Genome-Wide Association StudyAlzheimer DiseaseATP-Binding Cassette TransportersChromosomes, Human, Pair 7ClathrinEndocytosisEndosomal Sorting Complexes Required for TransportGenetic Predisposition to DiseaseGenetic VariationHumansMacular DegenerationMembrane GlycoproteinsPhosphoproteinsReceptors, ImmunologicRetinoid X ReceptorsRiskABCA7 protein, humanATP-Binding Cassette TransportersClathrinEndosomal Sorting Complexes Required for Transporthepatocyte growth factor-regulated tyrosine kinase substrateMembrane GlycoproteinsPhosphoproteinsPILRA protein, humanReceptors, ImmunologicRetinoid X ReceptorsTumor Necrosis Factor-alphaAge related macular degenerationAlzheimer diseaseGene-based testGenetic associationPathway analysis

Identifiers

PMID24439028
PMCPMC3961547
OpenAlexW2061905787

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.